Companion Diagnostic Kits
This technology will be packaged into two novel “Companion Diagnostic Kits”, introduced under the trade names SETAX™ and SEPEX™ to the market. These tests will predict drug efficacy in standard cancer chemotherapy with platinum-based drugs. We will offer all the required materials, including distinct instructions, for making a feasible clinical utilization of SETAX™ and SEPEX™ at the regular pathology laboratories. These tests will provide exclusive information for chemotherapy management, by identifying patients who gain benefit from the standard chemotherapy with platinum drugs. They can also be offered as a service, during the FDA clearance process for marketing SETAX™ and SEPEX™.
HOME | PRODUCT | TEAM MEMBERS | TECHNOLOGIES | MILESTONES | CONTACT US
